Ikarian Capital »

Aeglea Biotherapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.9M 302k 29.41

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option (BGNE)
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Aeglea Biotherapeutics

Fairmount Funds Management
Perceptive Advisors
VR Adviser
BlackRock
BlackRock
Braidwell
Commodore Capital
Vanguard Group
Deep Track Capital
State Street Corporation
Paradigm Biocapital Advisors
Assenagon Asset Management
Goldman Sachs Group
Geode Capital Management
Pictet Asset Management Holding SA

View all funds holding Aeglea Biotherapeutics